ClinicalTrials.gov
public full text
Public Domain
Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B
This Phase 3 clinical trial is a double blind, placebo-controlled, randomized, multicenter investigation of rBV A/B in male and female healthy adults 18 to 55 years of age.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older#143659
- Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older#234478
- Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine#471498
- Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older#253067
- Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge#1198129
Record · ID 1322808
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive